{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:40:23Z","timestamp":1791099623671,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ejpn.2011.03.006","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T09:28:32Z","timestamp":1303205312000},"page":"189-196","source":"Crossref","is-referenced-by-count":27,"title":["Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes"],"prefix":"10.1016","volume":"15","author":[{"given":"Nina","family":"Bari\u0161i\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Chaouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane S.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2011.03.006_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.20440","article-title":"Molecular architecture of the neuromuscular junction","volume":"33","author":"Hughes","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2011.03.006_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1113\/jphysiol.1967.sp008237","article-title":"The margin of safety of neuromuscular transmission","volume":"191","author":"Paton","year":"1967","journal-title":"J Physiol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/bja\/aep150","article-title":"Current concepts in neuromuscular transmission","volume":"103","author":"Fagerlund","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ejpn.2011.03.006_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coph.2004.12.007","article-title":"Current understanding of congenital myasthenic syndromes","volume":"5","author":"Engel","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000427","article-title":"Congenital myasthenic syndromes: spotlights on genetic defects of neuromuscular transmission","volume":"9","author":"M\u00fcller","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.ejpn.2011.03.006_bib6","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1073\/pnas.98.4.2017","article-title":"Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans","volume":"98","author":"Ohno","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejpn.2011.03.006_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/302059","article-title":"Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic)","volume":"63","author":"Donger","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib8","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1073\/pnas.95.16.9654","article-title":"Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme","volume":"95","author":"Ohno","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejpn.2011.03.006_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2011.03.006_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/hmg\/ddg089","article-title":"E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome","volume":"12","author":"Ohno","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib11","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/hmg\/ddh333","article-title":"MUSK, a new target for mutations causing congenital myasthenic syndrome","volume":"13","author":"Chevessier","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib12","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1073\/pnas.1230273100","article-title":"Myasthenic syndrome caused by mutation of the SCN4A sodium channel","volume":"100","author":"Tsujino","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejpn.2011.03.006_bib13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein Dok-7 is essential for neuromuscular synaptogenesis","volume":"312","author":"Okada","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejpn.2011.03.006_bib14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1130837","article-title":"Dok-7 mutations underlie a neuromuscular junction synaptopathy","volume":"3","author":"Beeson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejpn.2011.03.006_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2008.063693","article-title":"Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome","volume":"46","author":"Maselli","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajhg.2009.06.015","article-title":"Identification of an agrin mutation that causes congenital myasthenia and affects synapse function","volume":"85","author":"Huz\u00e9","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/00005072-199908000-00006","article-title":"Myopathy, myasthenic syndrome, and epidermolysis bullosa simplex due to plectin deficiency","volume":"58","author":"Banwell","year":"1999","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nmd.2010.06.003","article-title":"Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin","volume":"20","author":"Forrest","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2011.03.006_bib19","article-title":"Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE","author":"Maselli","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.nmd.2005.05.001","article-title":"126th International Workshop: congenital myasthenic syndromes, 24\u201326 September 2004, Naarden, the Netherlands","volume":"15","author":"Beeson","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2011.03.006_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/path.1832","article-title":"The origin of tubular aggregates in human myopathies","volume":"207","author":"Chevessier","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1440-1827.1999.00977.x","article-title":"Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system","volume":"49","author":"Oda","year":"1999","journal-title":"Pathol Int"},{"key":"10.1016\/j.ejpn.2011.03.006_bib23","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/sj.emboj.7600221","article-title":"Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders","volume":"23","author":"Cai","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.ejpn.2011.03.006_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12031-009-9229-0","article-title":"What have we learned from the congenital myasthenic syndromes","volume":"40","author":"Engel","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.ejpn.2011.03.006_bib25","first-page":"7","article-title":"Clinical variability of CMS-EA (congenital myasthenic syndrome with episodic apnea) due to identical CHAT mutations in two infants","volume":"9","author":"Barisic","year":"2005","journal-title":"EJPN"},{"key":"10.1016\/j.ejpn.2011.03.006_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejpn.2009.09.009","article-title":"Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations","volume":"14","author":"Schara","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nurt.2008.07.003","article-title":"Therapeutic strategies in congenital myasthenic syndromes","volume":"5","author":"Schara","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejpn.2011.03.006_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2009.02.017","article-title":"Congenital myasthenic syndrome with episodic apnea","volume":"41","author":"Mallory","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib29","doi-asserted-by":"crossref","first-page":"23233","DOI":"10.1074\/jbc.M301384200","article-title":"Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesterase","volume":"278","author":"Deprez","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejpn.2011.03.006_bib30","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1074\/jbc.M305462200","article-title":"C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse","volume":"279","author":"Kimbell","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ejpn.2011.03.006_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cbi.2005.10.110","article-title":"Acetylcholinesterase and molecular interactions at the neuromuscular junction","volume":"157-158","author":"Guerra","year":"2005","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ejpn.2011.03.006_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/1531-8249(200002)47:2<162::AID-ANA5>3.0.CO;2-Q","article-title":"The spectrum of mutations causing end-plate acetylcholinesterase deficiency","volume":"47","author":"Ohno","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1097-0029(20001101)51:3<247::AID-JEMT5>3.0.CO;2-Z","article-title":"Laminins of the neuromuscular system","volume":"51","author":"Patton","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.ejpn.2011.03.006_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/35097557","article-title":"Induction, assembly, maturation and maintenance of a postsynaptic apparatus","volume":"2","author":"Sanes","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.ejpn.2011.03.006_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/506257","article-title":"Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit","volume":"79","author":"Hoffmann","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ajhg.2007.11.006","article-title":"Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders","volume":"82","author":"Michalk","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jmg.2008.065425","article-title":"Germline mutation in DOK7 associated with fetal akinesia deformation sequence","volume":"46","author":"Vogt","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajhg.2007.09.016","article-title":"Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome\/fetal akinesia patients","volume":"82","author":"Vogt","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib39","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1073\/pnas.95.7.4007","article-title":"Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn","volume":"95","author":"Ramarao","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejpn.2011.03.006_bib40","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1074\/jbc.M009888200","article-title":"Role of rapsyn tetratricopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering","volume":"276","author":"Ramarao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejpn.2011.03.006_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuroscience.2006.03.035","article-title":"The tetratricopeptide repeat domains of rapsyn bind directly to cytoplasmic sequences of the muscle-specific kinase","volume":"141","author":"Antolik","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejpn.2011.03.006_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/mcne.1999.0779","article-title":"The intracellular domain of the\u00a0nicotinic acetylcholine receptor alpha subunit mediates its coclustering with rapsyn","volume":"14","author":"Maimone","year":"1999","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.ejpn.2011.03.006_bib43","doi-asserted-by":"crossref","first-page":"24911","DOI":"10.1074\/jbc.M103258200","article-title":"Interactions of the rapsyn RING-H2 domain with dystroglycan","volume":"276","author":"Bartoli","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejpn.2011.03.006_bib44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nmd.2003.11.004","article-title":"Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine","volume":"14","author":"Banwell","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2011.03.006_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-0004.2007.00824.x","article-title":"Congenital myasthenic syndrome caused by two non-N88K rapsyn mutations","volume":"72","author":"Maselli","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jmg.2010.081034","article-title":"Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing","volume":"47","author":"Gaudon","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nmd.2004.06.010","article-title":"A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome","volume":"14","author":"M\u00fcller","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2011.03.006_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nmd.2004.03.005","article-title":"Distinct phenotypes of congenital acetylcholine receptor deficiency","volume":"14","author":"Burke","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2011.03.006_bib49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nn1071","article-title":"Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction","volume":"6","author":"Finn","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ejpn.2011.03.006_bib50","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/bies.20305","article-title":"The synaptic muscle-specific kinase (MuSK) complex: New partners, new functions","volume":"27","author":"Strochlic","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.ejpn.2011.03.006_bib51","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.0b013e3181c3fce9","article-title":"Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes","volume":"73","author":"Mihaylova","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2011.03.006_bib52","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","article-title":"Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction","volume":"19","author":"Maselli","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib53","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","volume":"130","author":"M\u00fcller","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2011.03.006_bib54","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the DOK7 neuromuscular junction synaptopathy","volume":"130","author":"Palace","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2011.03.006_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ana.21408","article-title":"Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients","volume":"64","author":"Selcen","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib56","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.nmd.2009.09.008","article-title":"Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations","volume":"19","author":"Schara","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2011.03.006_bib57","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00415-009-5405-y","article-title":"Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7","volume":"257","author":"Ben Ammar","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib58","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/brain\/awl200","article-title":"Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with \u2019limb-girdle myasthenia\u2019","volume":"129","author":"Slater","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2011.03.006_bib59","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/hmg\/ddq049","article-title":"Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes","volume":"19","author":"M\u00fcller","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejpn.2011.03.006_bib60","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ijporl.2010.05.022","article-title":"Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome","volume":"74","author":"Jephson","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.ejpn.2011.03.006_bib61","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2011.03.006_bib62","doi-asserted-by":"crossref","first-page":"C868","DOI":"10.1152\/ajpcell.00604.2008","article-title":"Plectin contributes to mechanical properties of living cells","volume":"296","author":"Na","year":"2009","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379811000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379811000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T10:55:14Z","timestamp":1543834514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379811000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1090379811000419"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2011.03.006","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}